# Nuclide record johnson-johnson (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/johnson-johnson/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "johnson-johnson" ;
  schema:name "Johnson & Johnson"@en ;
  schema:alternateName "Alza Corporation"@en, "Janssen"@en, "Ortho Biotech Products, L.P."@en, "Ortho Biotech"@en, "Sequus Pharmaceuticals"@en, "Centocor, Inc."@en, "Centocor"@en, "Alza Corporation, DE, USA"@en, "Cougar Biotechnology, Inc."@en, "Cougar Biotechnology"@en, "McNeil Consumer & Specialty Pharmaceuticals"@en, "McNeil"@en ;
  schema:description "Johnson & Johnson leads in multiple myeloma (Darzalex, Carvykti, Tecvayli, Talvey) and in bispecific antibodies for lung cancer (Rybrevant)."@en ;
  schema:url <https://nuclide.cc/companies/johnson-johnson/>, <https://www.jnj.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Johnson_%26_Johnson> ;
  owl:sameAs <http://www.wikidata.org/entity/Q333718> ;
  schema:citation <https://www.jnj.com> ;
  schema:addressCountry "US" ;
  nuclide:drugs <https://nuclide.cc/drugs/jnj-87189401/> ;
  nuclide:trials <https://nuclide.cc/trials/nct04557059/> .